DRG International, Inc., a leading international medical diagnostic company, has released the first and only diagnostic kit to measure the hormone Hepcidin. In recent years, scientists discovered that Hepcidin helps regulate the amount of iron in humans. Unbalanced iron level can lead to many common medical conditions including anemia and iron overload diseases, or it can occur in chronic kidney disease, inflammation, or diabetes mellitus.
The DRG Hepcidin 25 (C-Terminal) ELISA Kit will be available to medical professionals worldwide, providing the first simple, fast and accurate method to test patient Hepcidin levels. The measurement results will offer more information to clinicians to help doctors diagnose and treat medical conditions including iron deficiency diseases, some of the most common diseases worldwide.
“With many health problems related to Hepcidin, the research team at DRG recognized the need to invent a testing kit, and put it in the hands of health professionals across the globe as soon as possible,” stated Dr. Cyril E. Geacintov, Chairman of DRG International. “This kit provides accurate information, is user-friendly, and will help meet the rapidly growing worldwide demand for such a testing kit.”
The new ELISA Hepcidin kit was jointly developed by research teams in the United States and Germany, under the strict standards of DRG International. The Hepcidin ELISA kit is fully patented and available worldwide. The inventors of these patents are Dr. Hasan Kulaksiz, Dr. Alfred Janetzko, and Dr. Cyril E. Geacintov.
